| Product Code: ETC4746676 | Publication Date: Nov 2023 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The import shipments of influenza vaccines to Grenada in 2024 show a diverse range of exporting countries, with Barbados, India, Panama, South Korea, and Belgium leading the pack. The market concentration, as measured by the HHI, has shifted from high to moderate in 2024, indicating a more balanced competitive landscape. The impressive Compound Annual Growth Rate (CAGR) of 24.01% from 2020 to 2024 reflects a strong and steady expansion in the market. Moreover, the remarkable growth rate of 67.54% from 2023 to 2024 highlights the increasing demand for influenza vaccines in Grenada.

The Influenza Vaccine market in Grenada is projected to grow at a stable growth rate of 1.53% by 2027, highlighting the country's increasing focus on advanced technologies within the North America region, where United States of America holds the dominant position, followed closely by Canada, Trinidad and Tobago, Jamaica and Bahamas, shaping overall regional demand.

The influenza vaccine market in Grenada is growing as public health initiatives and increasing awareness about flu prevention drive demand for seasonal vaccines. With the ongoing focus on vaccination to prevent the spread of contagious diseases, the influenza vaccine market is poised for steady growth, supported by government and healthcare efforts to improve public health.
The influenza vaccine market in Grenada is influenced by the increasing awareness of public health and the need for vaccination to prevent flu outbreaks. The push for vaccination programs in schools, hospitals, and workplaces drives demand for influenza vaccines.
The Grenada influenza vaccine market faces several obstacles, including limited access to cold chain storage and transportation infrastructure, which is critical for maintaining the vaccine`s efficacy. Additionally, there is a lack of awareness about the importance of vaccination, particularly in rural areas, where people may be more hesitant to receive the vaccine due to mistrust of health authorities or vaccine myths. Another significant challenge is the market`s dependency on imports, as Grenada does not have local vaccine manufacturing capabilities. This reliance can lead to supply chain disruptions, especially in cases of global vaccine shortages or delays. Furthermore, there are economic barriers, such as the affordability of vaccines, particularly for low-income populations, which can prevent widespread adoption of vaccination programs.
In Grenada, government policies in the influenza vaccine market focus on public health and access to vaccines. The government ensures the availability of affordable and effective flu vaccines for the population, working closely with international organizations to monitor vaccine efficacy and safety. There are public health campaigns to raise awareness about the importance of vaccination and initiatives to increase vaccine coverage, particularly during flu seasons.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Influenza Vaccine Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Influenza Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Influenza Vaccine Market - Industry Life Cycle |
3.4 Grenada Influenza Vaccine Market - Porter's Five Forces |
3.5 Grenada Influenza Vaccine Market Revenues & Volume Share, By Vaccine type, 2021 & 2031F |
3.6 Grenada Influenza Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Grenada Influenza Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Grenada Influenza Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Grenada Influenza Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Grenada Influenza Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Grenada Influenza Vaccine Market Trends |
6 Grenada Influenza Vaccine Market Segmentations |
6.1 Grenada Influenza Vaccine Market, By Vaccine type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Influenza Vaccine Market Revenues & Volume, By Quadrivalent, 2021-2031F |
6.1.3 Grenada Influenza Vaccine Market Revenues & Volume, By Trivalent, 2021-2031F |
6.2 Grenada Influenza Vaccine Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Grenada Influenza Vaccine Market Revenues & Volume, By Seasonal, 2021-2031F |
6.2.3 Grenada Influenza Vaccine Market Revenues & Volume, By Pandemic, 2021-2031F |
6.3 Grenada Influenza Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Grenada Influenza Vaccine Market Revenues & Volume, By Egg-based, 2021-2031F |
6.3.3 Grenada Influenza Vaccine Market Revenues & Volume, By Cell-based, 2021-2031F |
6.4 Grenada Influenza Vaccine Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 Grenada Influenza Vaccine Market Revenues & Volume, By Pediatric, 2021-2031F |
6.4.3 Grenada Influenza Vaccine Market Revenues & Volume, By Adult, 2021-2031F |
6.5 Grenada Influenza Vaccine Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Grenada Influenza Vaccine Market Revenues & Volume, By Injection, 2021-2031F |
6.5.3 Grenada Influenza Vaccine Market Revenues & Volume, By Nasal Spray, 2021-2031F |
7 Grenada Influenza Vaccine Market Import-Export Trade Statistics |
7.1 Grenada Influenza Vaccine Market Export to Major Countries |
7.2 Grenada Influenza Vaccine Market Imports from Major Countries |
8 Grenada Influenza Vaccine Market Key Performance Indicators |
9 Grenada Influenza Vaccine Market - Opportunity Assessment |
9.1 Grenada Influenza Vaccine Market Opportunity Assessment, By Vaccine type, 2021 & 2031F |
9.2 Grenada Influenza Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Grenada Influenza Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Grenada Influenza Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.5 Grenada Influenza Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Grenada Influenza Vaccine Market - Competitive Landscape |
10.1 Grenada Influenza Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Grenada Influenza Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here